REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,588,216 | +94804.6% | 94,039 | -15.4% | 0.00% | -25.0% |
| Q1 2023 | $10,103 | +148.3% | 111,121 | +3.7% | 0.00% | +100.0% |
| Q4 2022 | $4,069 | -99.9% | 107,115 | -3.0% | 0.00% | +100.0% |
| Q3 2022 | $2,775,000 | -19.7% | 110,433 | -2.8% | 0.00% | 0.0% |
| Q2 2022 | $3,454,000 | -13.4% | 113,646 | +7.7% | 0.00% | 0.0% |
| Q1 2022 | $3,987,000 | +55.2% | 105,532 | +8.3% | 0.00% | 0.0% |
| Q4 2021 | $2,569,000 | -75.6% | 97,415 | -7.1% | 0.00% | -66.7% |
| Q3 2021 | $10,548,000 | -55.2% | 104,836 | -37.0% | 0.00% | -57.1% |
| Q2 2021 | $23,561,000 | +83.9% | 166,467 | +29.5% | 0.01% | +75.0% |
| Q1 2021 | $12,813,000 | -18.1% | 128,506 | +1.6% | 0.00% | -20.0% |
| Q4 2020 | $15,639,000 | +58.6% | 126,505 | +25.0% | 0.01% | +25.0% |
| Q3 2020 | $9,861,000 | -43.0% | 101,220 | -8.8% | 0.00% | -42.9% |
| Q2 2020 | $17,315,000 | -36.5% | 110,980 | -41.2% | 0.01% | -46.2% |
| Q1 2020 | $27,262,000 | -18.6% | 188,875 | +15.2% | 0.01% | 0.0% |
| Q4 2019 | $33,511,000 | +139.6% | 163,926 | -5.9% | 0.01% | +116.7% |
| Q3 2019 | $13,984,000 | +9.5% | 174,165 | +28.7% | 0.01% | +20.0% |
| Q2 2019 | $12,767,000 | +2998.8% | 135,312 | +2708.5% | 0.01% | +150.0% |
| Q1 2019 | $412,000 | – | 4,818 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $288,821,000 | 55.24% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 100,000 | $9,970,000 | 15.20% |
| Tolleson Wealth Management, Inc. | 108,000 | $10,768,000 | 3.25% |
| MADDEN SECURITIES Corp | 34,787 | $3,468,000 | 2.03% |
| Biondo Investment Advisors, LLC | 101,204 | $10,090,000 | 2.01% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,027,000 | 1.91% |
| Duquesne Family Office | 749,897 | $74,765,000 | 1.65% |
| Sofinnova Investments, Inc. | 238,520 | $23,780,000 | 1.43% |
| Camber Capital Management LP | 400,000 | $39,880,000 | 1.37% |
| Integral Health Asset Management, LLC | 44,000 | $4,387,000 | 1.25% |